Biotin Injection vs Palmitoyl Tripeptide-1
A side-by-side research comparison of Biotin Injection and Palmitoyl Tripeptide-1 across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | Biotin Injection | Palmitoyl Tripeptide-1 |
|---|---|---|
| Full name | Biotin (Vitamin B7) Injectable | Palmitoyl Tripeptide-1 (Pal-GHK) |
| Category | Skin & Anti-Aging | Skin & Anti-Aging |
| Status | Compounded supplement | Research compound |
| Mechanism | Essential cofactor for carboxylase enzymes involved in keratin production, fatty acid synthesis, and amino acid metabolism critical for hair follicle health and nail matrix function. | Functions as matrikine signal, mimicking collagen fragments that trigger fibroblasts to produce new collagen. Palmitoyl enables deeper skin penetration. |
| Molecular weight | 244.31 Da | 578.8 Da |
| Half-life | ~2 hours | 8-12 hours (topical) |
| Bioavailability | ~100% injectable | Good (topical with lipid modification) |
| Typical dose | 1-10 mg IM | 2-5% in formulation |
| Frequency | 1-2x per week | 1-2x daily |
| Route | Intramuscular injection | Topical |
Biotin Injection reported benefits
- Hair growth support
- Nail strengthening
- Skin health
- Keratin production
- Metabolic support
Palmitoyl Tripeptide-1 reported benefits
- Collagen synthesis stimulation
- Matrix remodeling
- Wrinkle reduction
- Skin thickness increase
Related comparisons
Research and educational reference only. Not medical advice.